biotechDeep TechExit StrategyGilead SciencesGrowth StrategyHÍREKMedtechMiroBioNeed to KnowoxfordOxford Science EnterprisesspinoutThe South East of EnglandUniversity of OxfordVILÁG ANGOLGilead Sciences acquires Oxford spinout MiroBio for £334mMOCOHUAugust 7, 2022 by MOCOHUAugust 7, 20220 US biopharmaceutical company Gilead Sciences is acquiring Oxford-based biotech startup MiroBio in a cash deal valued at approximately $405m (£333.9m). Spun out of the University...